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SI Methods
Cells, Antibodies, and Mice.Madin–Darby canine kidney (MDCK)
type II cell line was a gift from Keith Mostov (University of
California School of Medicine, San Francisco, CA). MDCK-rat
FcRn (Fc receptor for IgG), MDCK-vector, and MDCK-rat
FcRn-GFP cells have been previously described (1). Cells were
grown in DMEM complete medium supplemented with 10 mM
Hepes, 10% FCS, 1% L-glutamine, nonessential amino acids
(Invitrogen), and 1% penicillin/streptomycin (Invitrogen Life
Technologies). When necessary, media were also complemented
with 400 μg/mL of G418 (Invitrogen). Cells were grown in 5%
CO2 at 37 °C. mAb anti-EEA1 was obtained from BD Bio-
sciences. Goat anti-mouse polymeric IgA receptor (pIgR) was
from R&D Systems. Mouse anti-canine LAMP-2 was from AbD
Serotec, and anti–β-tubulin antibody was obtained from the
Developmental Studies Hybridoma Bank, developed under the
auspices of the National Institute of Child Health and Human
Development and maintained by the University of Iowa. ZO-1–
speciﬁc antibody was obtained from Invitrogen. Alexa Fluor-
conjugated 488, 555, and Alexa Fluor 633 goat anti-mouse or
rabbit antibodies were purchased from Molecular Probes. Af-
ﬁnity-puriﬁed rabbit IgG against mouse FcRn was previously
described (2). HRP-conjugated donkey anti-rabbit or rabbit
anti-mouse antibody was purchased from Pierce Biotechnology.
Afﬁnity-puriﬁed mouse IgG and chicken IgY were obtained
from Rockland Immunochemicals. Sulfo-NHS-LC-biotin was
from Pierce.
Male inbred C57BL/6 mice aged 6 to 8 wk were purchased from
Charles River Laboratories. The FcRn-KO mice in a C57BL/6
background were from Jackson Laboratory. All mice were housed
in speciﬁc pathogen-free animal resources facility. All animal
studies were reviewed and approved by the institutional animal
care and use committee at the University of Maryland.
Virus and mAb. Inﬂuenza A virus (strain A/Puerto Rico/8/1934
H1N1) was a gift from Peter Palese (Mount Sinai School of
Medicine,NewYork,NY). InﬂuenzaPR8viruswas grown in 10- to
11-d-old embryonated chicken eggs. Puriﬁcation of the virus was
performed by differential centrifugation and sedimentation
throughasucrosegradient.PR8HA-speciﬁchybridomaY8(IgG2a)
and H36-4 (IgG2a) were from Coriell Institute for Medical Re-
search,andtheNP-speciﬁchybridomaHB-65(IgG2a)wasfromthe
American Type Culture Collection. These mAbs have been de-
scribed previously (3). Puriﬁcation of mAb from cell culture me-
dium was done by afﬁnity chromatography using Protein A
(Pierce), dialyzed against PBS solution and stored in PBS solution
at −80 °C. Inﬂuenza virus (2 mg/mL) was biotinylated by using
150 μMsulfo-NHS-SS-biotin (Pierce) according tomanufacturer’s
instructions, and free biotin was completely removed by desalting
column (Pierce).
SDS/PAGE, Western Blot, and Avidin Blot. Protein concentrations
were determined by Bradford assay (Bio-Rad Laboratories).
Then, proteins or biotin-labeled proteins were resolved on a 12%
SDS/PAGE gel under reducing conditions. Proteins were trans-
ferred onto a nitrocellulose membrane (Schleicher and Schuell).
The membranes were blocked with 5% nonfat powered milk,
probed separately with anti-FcRn, anti-pIgR, or β-tublin Ab for
1 h, and followed by incubating with HRP-conjugated rabbit
anti-mouse IgG, HRP-conjugated donkey anti-rabbit IgG or
HRP-avidin, respectively. All blocking, incubating, and washing
were performed in PBS solution with 0.05% Tween 20. Proteins
were visualized by the ECL method (Pierce).
TCID50 Assay and Hemagglutination Inhibition Assay. TCID50 was
determined in MDCK cells. Samples were serially diluted 10-fold
in Opti-MEM I (Invitrogen). MDCK cells were plated 1 d before
PR8 infection in 96-well plates. MDCK conﬂuent monolayers
were then infected with the diluted virus for 1 h at 37 °C. In-
fected cells were subsequently washed and incubated with fresh
medium supplemented with 1 μg/mL TPCK-trypsin (Sigma) for
72 h. Supernatant were collected and the endpoint viral titer was
determined by a hemagglutination assay.
The antiviral activity of PR8 HA speciﬁc mAb was measured
by standard hemagglutination inhibition (HI) assay with minor
modiﬁcations. Approximately four hemagglutination units of PR8
viruseswere incubatedatpH5.0orpH7.4Opti-MEMfor2hat4°C.
Spin desalting columnswere used to exchange the buffer to neutral
pH (7.4). Y8 or H36 mAbs were serially diluted 10-fold in V-
bottom 96-well plates and incubated for 1 h at room temperature
with viruses treated at different pH values. Subsequently, 1%
chicken red blood cells were added and incubated for 30 min
at room temperature. The highest serum dilution that inhibited
hemagglutination was considered the HI titer of the mAb.
In Vitro and in Vivo Transcytosis. IgG transcytosis in MDCK mon-
olayers was measured by a modiﬁcation of previously described
methods (1). MDCK cells expressing rat FcRn or FcRn-GFP, and
MDCK-vector control, were grown onto 0.4-μm pore size trans-
well ﬁlter inserts (Corning Costar) to form a monolayer exhibiting
transepithelial electrical resistances (300 Ω/cm2). Transepithelial
electrical resistance was measured by using a volt-ohm meter
equipped with planar electrodes (World Precision Instruments).
Monolayers were equilibrated in Hanks balanced salt solution.
IgG, IgG-biotin, or IgY-biotin (400 μg/mL) were applied to the
basolateral compartment in pH 7.4 serum-free DMEM (In-
vitrogen) supplemented with 10 mM Hepes, 10 mM sodium py-
ruvate, 1% L-glutamine, 1% nonessential amino acids, and 1%
penicillin/streptomycin, and incubated for 2 h at 37 °C. Trans-
ported proteins were sampled from the apical chamber and ana-
lyzed by SDS/PAGE under reducing conditions. Proteins were
visualized by Western blot-ECL or avidin blot-ECL analysis. For
in vivo IgG or IgY transport, 200 μg of biotinylated mouse IgG or
chicken IgY in 100 μL of PBS solution were injected i.p. into mice.
Lung lavages were collected 24 h later. The transported IgG-
biotin or IgY-biotin antibody was analyzed by SDS/PAGE and
Western blot-ECL or avidin blot-ECL analysis (Pierce).
Intracellular Neutralization of PR8 Virus by Y8 mAb.Y8 IgG (400 μg/
mL) or an irrelevant murine IgG2a antibody was applied to the
lower compartment when MDCK-FcRn or MDCK-vector cell
monolayers become polarized on insert ﬁlters. Cells were in-
cubated with IgG antibody for 2 h at 37 °C. Subsequently, PR8
virus (100 pfu/cell) was inoculated into the apical chamber for
1.5 h at 4 °C; then, cells were warmed to 37 °C for an additional
45 min to allow infection. Inserts were completely washed to
remove the residual antibody or virus. Cells were incubating for
additional 24 h at 37 °C, at which time the apical supernatants
were removed. The apical supernatants were tested for virus
titers by TCID50.
Nocodazole Treatment.MDCK transfectants (1 × 105) were seeded
onto the transwell to allow polarization. Cells were preincubated
with or without nocodazole (33 μm) for 2 h; nocodazole was then
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removed from the chambers. Y8 mAb (400 μg/mL) was sub-
sequently added into the basolateral chamber to allow transport
for 2 h. PR8 virus was added to the apical chamber for 45 min
to allow infection. Cells were completely washed to remove the
IgG or virus and incubated for an additional 24 h at 37 °C. The
amount of PR8 virus in the apical medium was analyzed by a
TCID50 assay.
RT-PCR Analysis. For total RNA extraction, cells were pelleted and
resuspended in TRIzol reagent (Invitrogen Life Technologies).
The inﬂuenza PR8 NP gene was ampliﬁed by primers (5′-AT-
CATGGCGTCTCAAGGCAC-3′, 5′-TCCTGTATATAGGTC-
CTC-3′) with an One-Step RT-PCR kit (Qiagen). The RNA was
also ampliﬁed by using GAPDH-speciﬁc primers (5′-GGAG-
AAAGCTGCCAAATATG-3′, 5′-TACCAGGAAATGAGCT-
TGAC-3′) as an internal control to monitor the quality of the
RNA puriﬁcation and cDNA synthesis. The PCR products were
analyzed by 1.5% agarose gel electrophoresis and stained with
ethidium bromide.
Immunoﬂuorescence and Confocal Microscopy. Immunoﬂuores-
cence staining of cells or frozen tissue sections was performed
based on methods previously described (2). Brieﬂy, cells were
cultivated on coverslips for 24 h and subsequently incubated with
Y8 for 2 h at 37 °C. Next, antibody-treated cells were incubated
with biotin-labeled virus for 30 min. The cells were rinsed in PBS
solution, ﬁxed in 3.7% paraformaldehyde (Sigma) in PBS solu-
tion for 30 min at 4 °C, and quenched with 10% glycine for
10 min. After two washings with PBS solution, the coverslips
were permeabilized in PBS solution containing 0.2% Triton X-
100 for 20 min. The frozen tissues were embedded in optimal
cutting temperature media, serially sectioned, ﬁxed in acetone
for 5 min at −20 °C, and air-dried for 30 min. Both cells and
tissue sections were blocked with 10% normal goat serum for
30 min and stained with afﬁnity-puriﬁed primary antibodies in
PBS solution with 0.05% Tween 20 with 3% BSA for 1 h, fol-
lowed by Alexa Fluor 555- or Alexa Fluor 488-conjugated anti-
IgG antibodies of the corresponding species in blocking buffer.
Biotinylated virus was detected by using streptavidin conjugates
labeled with Alexa Fluor 488 (Molecular Probes). After each step,
cells were washed at least three times with PBS solution con-
taining 0.05% Tween-20. Coverslips were mounted on slides with
ProLong antifade reagent (Molecular Probes) and examined by
using a Zeiss LSM 510 confocal ﬂuorescence microscope. The
images were processed by using LSM Image Examiner software
(Zeiss). Quantitative colocalization measurement was performed
by using Zeiss LSM 510 Examiner Software. Pearson correlation
coefﬁcient was calculated for describing the colocalization corre-
lation of the intensity distributions between two channels as pre-
viously described (2).
Analysis of Intracellular Distribution of Nucleoprotein Protein After
PR8 Infection in Presence or Absence of Y8 mAb.MDCK-FcRn cells
were cultivated on coverslips for 24 h. Cells were treated with
400 μg/mL Y8 mAb or isotype-matched IgG for 1 h. Cells were
infected with PR8 virus at a multiplicity of infection of 100 pfu/
cell at 4 °C for 1.5 h . After they were washed with cold PBS
solution three times, cells were shifted to 37 °C in culture me-
dium and collected at 10, 30, 45, 60, 120, or 240 min. Cells were
stained with primary anti-EEA1, LMAP-2, and anti-NP mAb.
Other staining procedures are the same as the described for
immunoﬂuorescence and confocal microscopy. Quantitative co-
localization measurements were performed by using Zeiss LSM
510 Examiner Software. Pearson correlation coefﬁcients were
calculated for describing the colocalization correlation of in-
tensity distributions between the two channels. In the quantita-
tive experiment with MDCK-FcRn cells, 10 cells per view ﬁeld
were analyzed. P < 0.05 was considered as signiﬁcant.
Passive Protection of WT and FcRn KO Mice Against PR8 Virus by mAb.
Groups of ﬁve mice were injected i.p. with 100 μL of PBS solution
with 100 μg Y8 or mouse IgG 4 h before challenge to allow
distribution and equilibration of antibody to all tissues before
virus inoculation. One group of ﬁve mice was mock-immunized
with PBS solution following the same schedule. Mice were in-
oculated with 500 pfu PR8 viruses intranasally under an anes-
thesia induced with 100 μL of 40 mg/mL tribromoethanol
(Avertin; Sigma). Mice were kept on their backs under the in-
ﬂuence of anesthesia for 45 min to allow infection. Mice were
monitored for 10 d for illness and death. Body weight changes
were recorded on a daily basis. For virus titration in the lung,
viruses were inoculated into MDCK cells and cultured for 3 d,
and TCID50 values were measured. Experiments were per-
formed at least three times.
Pathology. To assess pulmonary inﬂammation after PR8 virus
infection, lungs were taken from experimental mice to examine
the gross pathologic changes after biopsy. Lungs were also im-
mediately placed in 10% neutral buffered formalin and sent to
American HistoLabs, where they were embedded in parafﬁn and
stained with H&E to visualize cellular inﬂammation. Slides were
coded and read “blind.”
Statistics. All results are expressed as geometric mean titers with
SD of at least three independent experiments. Statistical signif-
icance was determined by Student t test (two-tailed) and the level
of signiﬁcance was set at P < 0.05. For animal survival data,
statistical signiﬁcance was determined by the log-rank test (Ka-
plan–Meier survival analysis). The analyses were conducted by
using GraphPad Prism.
SI Results
Characterization of Inﬂuenza PR8-Speciﬁc Y8 mAb.Mouse IgG2a Y8
mAb binds to the globular domain of HA. Its cognate epitope
is located at the interface of adjacent subunits. For this reason,
Y8 mAb can bind inﬂuenza virus PR8 HA monomers but not
native trimers (4). We further characterized the Y8 mAb in
comparison with another HA-speciﬁc neutralizing mAb, H36-4,
which can bind HA native trimers. Conﬂuent MDCK cells were
infected with inﬂuenza virus for 1.5 h at 4 °C to allow virus at-
tachment to the cell surface and then at 37 °C for 30 min to
permit viral endocytosis. The monolayers were stained with Y8
or H36-4 mAb with or without permeabilizing the cells. As
shown in Fig. S1A, H36-4 mAb incubation resulted in a granular
appearance of ﬂuorescence staining; in contrast, antibody Y8
remained unreactive with virus particles adsorbed to the cell
surface. Consistent with Fig. S1A, H36-4, but not Y8 mAb, can
react with surface virus (Fig. S1B). When the infected cells were
warmed to 37 °C for 30 min before staining, both the H36-4 and
Y8 mAbs reacted with the virus particles in permeabilized cells,
as shown by the presence of discrete ﬂuorescent spots in the
cytoplasm (Fig. S1B), suggesting the Y8 mAb only recognizes
intracellular HA. To further evaluate the difference of binding
activity between the Y8 and H36-4 mAb, inﬂuenza virus PR8 was
incubated with Y8 or H36-4 mAb in pH 5.0 or 7.4 buffer,
readjusted to pH 7.4, and followed by HI assay. Treatment of
puriﬁed inﬂuenza virus at pH 5.0 leads to irreversible confor-
mational alterations in HA proteins (3). As shown in Fig. S1C,
the H36-4 mAb had potent HI activity at acidic and neutral pH;
however, the Y8 mAb had HI activity only at an acidic pH. These
results demonstrate that, unlike H36-4 mAb, Y8 mAb can only
detect PR8 HA in conformational alterations induced by an
acidic pH. Our data are in agreement with previous ﬁndings that
Y8 binds HA on intact virions in a manner dependent upon
conformational changes that accompany acidic activation of viral
fusion activity (4). Therefore, the pH sensitivity of Y8 mAb
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provides a unique tool to investigate the potential of FcRn-
mediated IgG transport to block viral infection in epithelial cells.
Neutralization of Inﬂuenza PR8 Virus by Y8 mAb Is Dependent on IgG
Transcytosis. Nocodazole, a reversible inhibitor of microtubule
polymerization, has been shown to efﬁciently block IgG trans-
cytosis (5). We showed that preincubation of MDCK-FcRn
monolayers with 33 μm nocodazole abolished the apically di-
rected transport of Y8 IgG in a transcytosis assay (Fig. S3B).
Likewise, the virus titers in MDCK-FcRn/IgG cells that were
pretreated with nocodazole reached comparable levels as those
observed in untreated MDCK-vector cells. Although it was not
tested directly, it is expected that MDCK cells will return to
a normal cell state following nocodazole removal, thus, the 2-h
nocodazole pretreatment should not signiﬁcantly impact normal
viral replication during the subsequent 24-h incubation.
In Vivo Transcytosis of Y8 mAb. By Western blot analysis, FcRn is
highly expressed in respiratory epithelial cells (Fig. 4A and Fig.
S4). We subsequently tested whether murine FcRn can mediate
IgG transport across the airway mucosal barrier in WT vs. FcRn-
KO mice. We administrated biotin-IgG into WT (100 μg) or
FcRn-KO (200 μg) mice i.p. The rationale for injecting twofold
more IgG into FcRn-KO mice is both endogenous and injected
IgG will exhibit fast clearance in these mice; thus, more IgG is
required in FcRn-KO mice to obtain comparable exposure lev-
els. As a speciﬁcity control, we also injected 200 μg of chicken
IgY-biotin into the WT mice. Lung bronchoalveolar lavage
(BAL) samples were taken 24 h after each injection and sub-
jected to avidin blot analysis. IgG was detected in the BAL of
WT mice (Fig. 4B). The failure to detect IgG in FcRn KO mice
and chicken IgY in WT mice is consistent with speciﬁc transport
of IgG by across alveolar tissue by FcRn in vivo.
Expressions of FcRn and pIgR in Mouse Airway Tissues. Although
both IgA and IgG are transcytosed by Fc receptors (6), IgG is the
major Ig isotype detected in human bronchoalveolar ﬂuid. We
reasoned that the differential expression levels of FcRn and
pIgR, which transcytoses IgA through the polarized epithelial
cells, might explain this discrepancy in the BAL. We thus ex-
amined the levels of mouse FcRn and pIgR expression in the
lung and trachea of adult mice by immunoﬂuorescence staining
(Fig. S4) and Western blot analysis (Fig. 4A). The liver and in-
testine were used as controls. FcRn was detected in the epithelial
cells of both trachea and lung (Fig. 4A and Fig. S4). However,
the pIgR was barely detectable in the lung alveolar epithelial
cells, although it was detected in the bronchial and tracheal
epithelial cells. As expected, the pIgR was abundant in the ep-
ithelial cells of the liver and small intestine. However, mouse
FcRn was detected in only the liver (Fig. 4A). These results may
explain why large amounts of IgG, but not IgA, appear in the
BAL. This observation may have biological signiﬁcance for
antibody-mediated immunity against respiratory infections in
lung tissues.
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Fig. S1. Characterization of inﬂuenza PR8 HA speciﬁc monoclonal antibody. (A and B) MDCK cells or their transfectants (1 × 106) were infected with inﬂuenza
virus PR8 (100 pfu/cell) for 1.5 h at 4 °C (A) or switched to 37 °C (B) for 30 min. Cells were ﬁxed with 3.7% paraformaldehyde for 15 min under either non-
permeabilized or permeabilized (0.2% Triton X-100 in PBS solution) conditions as indicated. Cells were incubated with afﬁnity-puriﬁed PR8 HA-speciﬁc IgG
mAb H36-4 (H36) or Y8 (400 μg/mL), followed by Alexa Fluor 488-conjugated IgG (green). Staining was not observed in the presence of isotype matched IgG.
Images were originally obtained at a magniﬁcation of 40×. (Scale bars: 5 μm.) (C) HI titer of H36 and Y8 mAb under different pH conditions. H36 or Y8 mAb
(400 μg/mL) was incubated with PR8 virus at pH 5.0 or pH 7.4 buffer conditions for 1 h, readjusted to pH 7.4, and followed by HI assay with 0.5% chicken red
blood cells for 30 min at room temperature. HI titers were expressed as the reciprocal of the highest dilution of the mAb that completely inhibited hem-
agglutination (**P < 0.01).
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Fig. S2. Transcytosis of Y8 IgG. MDCK-FcRn cells were loaded with biotin-Y8 IgG (lane 2) or biotin-chicken IgY (lane 3) at 37 °C, or biotin-Y8 IgG at 4 °C (lane 4)
in basolateral chamber. Medium was collected from the apical side 2 h later and subjected to SDS/PAGE and avidin blot-ECL analysis. IgG or IgY heavy chain
(HC) and light chain (LC) are indicated (STD, standard). Intact Y8 IgG, but not chicken IgY, applied to the basolateral side was transported across this MDCK-
FcRn monolayer at 37 °C, thus conﬁrming that the observed transcytosis is mediated by FcRn.
Fig. S3. Detection of the PR8 NP gene. (A) Total RNA was extracted from PR8-infected MDCK-FcRn or MDCK-vector cells by TRIzol reagent during transcytosis.
The inﬂuenza PR8 NP or GAPDH gene was ampliﬁed by one step RT-PCR as described inMethods. GAPDH was used as an internal control to monitor the quality
of the RNA puriﬁcation and cDNA synthesis. The PCR products were analyzed by 1.5% agarose gel electrophoresis and stained with ethidium bromide. (B)
Densitometry analysis of ampliﬁed NP cDNA band intensities normalized to GAPDH (**P < 0.01).
Fig. S4. Neutralization of inﬂuenza PR8 virus by Y8 mAb is dependent on IgG transcytosis. MDCK-FcRn, MDCK-FcRn-GFP, and MDCK-vector cells (1 × 105/well)
were grown in a 0.4-μm 12-well transwell insert and allowed to polarize. (A) The polarized MDCK-FcRn, MDCK-FcRn-GFP, and MDCK-vector cells were loaded
with biotin-Y8 IgG (400 μg/mL) at 37 °C in basolateral chamber. Medium was collected from the apical compartment 2 h later, and subjected to SDS/PAGE
electrophoresis and avidin blot-ECL analysis. IgG heavy chain (HC) and light chain (LC) are indicated by arrows to the left of the IgG standard (STD, lane 1). (B)
Polarized MDCK-FcRn or MDCK-vector cells were incubated in the absence (lane 2) or presence (lane 3) of nocodazole (33 μM) for 2 h, and nocodazole was then
removed; subsequently, Y8 mAb (400 μg/mL) was added into the basolateral chamber to allow apically directed transport of Y8 IgG. Medium was collected
from the apical compartment 2 h later, and subjected to SDS/PAGE electrophoresis and avidin blot-ECL analysis. IgG heavy chain (HC) and light chain (LC) are
indicated by the arrowheads to the left of the IgG standard (STD, lane 1). (C) Polarized MDCK-FcRn or MDCK-vector cells were incubated in the presence or
absence of nocodazole (33 μM) for 2 h, and nocodazole was then removed from the chambers. Y8 mAb (400 μg/mL) was added into the basolateral chamber for
2 h to allow apically directed transport of Y8 IgG. PR8 virus was added to the apical chamber for 45 min at 4 °C to allow for infection. Cells in both chambers
were completely washed to remove the residual IgG or virus. Cells were then incubated for an additional 24 h at 37 °C. The amount of PR8 virus in the apical
medium was analyzed by a TCID50 assay (*P < 0.05).
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Fig. S5. Colocalization of FcRn, EEA1, IgG, and PR8 virus in MDCK-FcRn cells. MDCK-FcRn cells grown on coverslips were incubated with 200 μg Y8 Ab for 2 h at
37 °C and the monolayers were then rinsed with cold PBS solution to remove residual Ab. Subsequently, the cells were infected with inﬂuenza PR8-biotin for
1 h, and then washed, ﬁxed, and permeabilized. The cells were incubated with afﬁnity-puriﬁed rabbit anti-FcRn and mAb anti-EEA1, followed by Alexa Fluor
488-, 555-, or 633-conjugated IgG of the corresponding species. Punctuate staining that appears in yellow in the merged images (Upper) indicates colocali-
zation of FcRn with the IgG or virus. Similar results were observed from three independent experiments. (Scale bars: 5 μm.)
Fig. S6. (A) Western blots analysis of mouse FcRn expression. Epithelial cell lysates (50 μg) from the trachea, lung, liver, and intestine in FcRn WT and KO mice
were subjected to SDS/PAGE. Immunoblotting was performed with the primary antibodies and HRP-conjugated secondary antibodies corresponding to dif-
ferent species. Blots were developed with ECL. (B) IgG transport across the lung mucosal barrier. The 100-μg (lane 3) or 200-μg (lane 4) biotin-labeled IgG and
200 μg chicken IgY (lane 6) were intraperitoneally administrated into WT and FcRn KO mice. PBS solution was used as a negative control. Twenty-four hours
later, BALs were sampled and subjected to SDS/PAGE. The proteins were blotted with HRP-conjugated avidin and developed with ECL. IgG or IgY heavy chain
(HC) and light chain (LC) are indicated by arrows (STD, standard).
Fig. S7. Immunohistochemical staining of mouse FcRn expression in adult mice. Frozen sections of trachea, lung, and intestine tissues obtained from WT or
FcRn KO mice were stained with afﬁnity-puriﬁed rabbit anti-FcRn or anti-pIgR antibody (2 μg/mL) and followed by Alexa Fluor 488-conjugated IgG (green).
FcRn or pIgR staining was not observed in the presence of control IgG. The nucleus is stained with DAPI (blue). The data are representative of sections from at
least three independent mice. Images were originally obtained at a magniﬁcation of 40×. (Scale bars: 20 μm.)
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Fig. S8. Proposed model for IgG-mediated intracellular neutralization by FcRn in polarized epithelial cells. (A) FcRn transports IgG bidirectionally. (B) IgG is
transcytosed and secreted into the lumen, where it can combine antigens to form immune complexes. (C) In a cell that has been infected by a virus,
a transcytotic vesicle containing antiviral IgG has the opportunity to meet virus. IgG neutralizes the virus inside vesicles and therefore aborts viral replication by
delivery of these particles to lysosomes for degradation.
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